Fig. 1

Flowchart of study patient enrollment. TNBC: triple-negative breast cancer; NACI: neoadjuvant chemoimmunotherapy: DCE-MRI: dynamic contrast-enhanced magnetic resonance imaging
Flowchart of study patient enrollment. TNBC: triple-negative breast cancer; NACI: neoadjuvant chemoimmunotherapy: DCE-MRI: dynamic contrast-enhanced magnetic resonance imaging